Theravance Biopharma Inc
Biotechnology
Healthcare
TBPH
49.71 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
14.02
52 week high
14.47
high
14.12
52 week low
0.00
low
13.94
growth
75.66 %
previous Close
14.07
P/E ratio
market cap
558 M
div yield
0
usd
Mar 2025
qoq
revenue
15.39 M
-17.95 %
net incoming
-13.58 M
12.55 %
eps
0.00 %
-246.11 %
eps surprise
-92.67 %
net profit margin
-88.24 %
-5.00 %
operating incoming
-14.43 M
-56.89 %
net change in cash
72.82 M
405.01 %
cash on hand
111 M
192.65 %
cost of revenue
0.00 %
top top